Retaglutide is a innovative GLP-1 receptor agonist currently under study for the control of obesity. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://victormfnl505312.pages10.com/trelaglutide-exploring-a-new-option-for-chronic-diseases-74308244